Antifungal therapy for chronic rhinosinusitis: The controversy persists

Matthew A. Rank, Cheryl R. Adolphson, Hirohito Kita

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Purpose of review Chronic rhinosinusitis is a debilitating disease seen frequently by allergist- immunologists. Recent research examining the pathophysiological mechanisms and treatment options for chronic rhinosinusitis have yielded contradicting results, particularly in regard to the role of fungi and antifungal therapies. Recent findings Recent studies using antifungal therapies for chronic rhinosinusitis will be critically evaluated with careful attention to sample selection, length of the intervention, drug delivery system, drug stability and handling, assessment of compliance to study medications, and choice of outcome measures with attention to study power (both primary and secondary). Using this framework to evaluate currently available studies reveals limitations in studies showing a benefit for antifungal therapy and in studies showing no benefit (or harm). Summary Limitations in studies that either support or refute the benefit of antifungal therapy for chronic rhinosinusitis prevent any firm conclusions about its efficacy.

Original languageEnglish (US)
Pages (from-to)67-72
Number of pages6
JournalCurrent Opinion in Allergy and Clinical Immunology
Issue number1
StatePublished - Feb 2009


  • Amphotericin B
  • Antifungal
  • Sinusitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Antifungal therapy for chronic rhinosinusitis: The controversy persists'. Together they form a unique fingerprint.

Cite this